Yuheinoside exhibits significant potential in pharmaceutical applications, particularly in anti-inflammatory and neuroprotective therapies. It has demonstrated the ability to modulate key signaling pathways involved in oxidative stress and neuronal damage, making it a candidate for research in neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease. Additionally, studies suggest antitumor properties, where it induces apoptosis in certain cancer cell lines through mitochondrial pathways. Its bioactive profile also supports exploration in metabolic disorder treatments, including diabetes-related complications due to its antioxidant effects. Ongoing research focuses on enhancing bioavailability and evaluating in vivo efficacy for future therapeutic development.